Related Experiment Video
Updated: Aug 14, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Causal Uncertainty-Decomposed Ensemble Learning for Confounding-Aware Skin Cancer Detection in Dermoscopic Images
Mohd Faheem Khan1, Khurshid Ahmad2
1Department of Biotechnology and Microbiology, Khandelwal College of Management, Science and Technology, M.J.P. Rohilkhand University, Bareilly 243122, Uttar Pradesh, India.
This study introduces a causal uncertainty-decomposed ensemble (CUDE) to improve skin cancer detection by reducing reliance on image artifacts. CUDE enhances model robustness and accuracy in classifying skin lesions.
Area of Science:
- Artificial Intelligence
- Medical Imaging
- Dermatology
Background:
- Automated dermoscopic image analysis aids early skin cancer detection.
- Deep learning models may exploit acquisition artifacts (hairs, shadows) instead of lesion features.
- Confounding factors in image data can hinder diagnostic accuracy.
Purpose of the Study:
- Evaluate a causal uncertainty-decomposed ensemble (CUDE) for confounding-aware skin lesion classification.
- Assess CUDE's robustness against acquisition-related shortcuts in dermoscopic images.
- Improve the reliability of AI models for early skin cancer detection.
Main Methods:
- CUDE employs a structured variational autoencoder (SVAE) with separate latent heads for lesion and nuisance factors.
- Three stochastic latent-space experts are trained and fused using a Dirichlet-based module.
- Nuisance sampling and a causal graph prior are utilized for improved model training.
Main Results:
- CUDE achieved 89.7% balanced accuracy and 0.972 AUROC on the ISIC 2019 benchmark.
- CUDE demonstrated a 5.0% relative performance drop with synthetic artifacts, outperforming deep ensembles (9.6%).
- Deferring uncertain cases improved accuracy to 93.2% and reduced false negatives for melanoma, BCC, and SCC.
Conclusions:
- Structured latent separation, expert diversity, and Dirichlet fusion enhance robustness and calibration in benchmark settings.
- CUDE shows promise for more reliable AI-based skin lesion classification.
- Further validation across diverse clinical settings, devices, and skin tones is essential for real-world deployment.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confocal Fluorescence Microscopy